snoRNAs contribute to myeloid leukaemogenesis

Area of Science:

• Molecular Biology
• Oncology
• Gene Regulation

Background:

• The precise role of oncogenes in acute myeloid leukaemia (AML) pathogenesis remains unclear.
• Understanding oncogene-driven mechanisms is crucial for developing targeted AML therapies.

Purpose of the Study:

• To elucidate the mechanism by which the AML1-ETO fusion oncoprotein contributes to leukaemogenesis.
• To investigate the role of small nucleolar RNAs (snoRNAs) in AML driven by AML1-ETO.

Main Methods:

• Analysis of gene expression profiles in AML cells.
• Investigating post-transcriptional regulation of snoRNAs by AML1-ETO.
• Assessing the impact of altered snoRNA levels on ribosomal RNA methylation and protein translation.

Main Results:

• The AML1-ETO oncoprotein was found to upregulate the expression of specific small nucleolar RNAs.
• This upregulation occurs through post-transcriptional regulatory mechanisms.
• Increased snoRNA levels correlated with enhanced ribosomal RNA methylation and protein synthesis.
• Overexpression of AML1-ETO promoted leukaemic cell self-renewal and proliferation.

Conclusions:

• The AML1-ETO oncoprotein promotes acute myeloid leukaemia by modulating small nucleolar RNA expression.
• This pathway enhances key cellular processes, including protein translation and leukaemic cell growth.
• Targeting the AML1-ETO/snoRNA axis may offer a novel therapeutic strategy for AML.